Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Treatment Options in Cardiovascular Medicine
Erschienen in: Current Treatment Options in Cardiovascular Medicine 5/2020

01.05.2020 | Coronary Artery Disease (D Feldman and V Voudris, Section Editors)

Improving Outcomes With IVUS Guidance During Percutaneous Coronary Interventions

verfasst von: Vinayak Nagaraja, Ankur Kalra, Rishi Puri

Erschienen in: Current Treatment Options in Cardiovascular Medicine | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

This review highlights the evidence surrounding the adjunctive diagnostic and therapeutic benefits of intravascular ultrasound (IVUS) during percutaneous coronary intervention (PCI).

Recent findings

Meta-analyses of randomized trials demonstrate that IVUS has a major impact on PCI-related outcomes with drug-eluting stents by reducing cardiovascular mortality and repeat revascularization. Its application in calcific coronary artery disease has helped identify the benefits and safety of coronary atherectomy, along with playing an important role for primarily guiding PCI while significantly reducing contrast volume in individuals with renal dysfunction. IVUS applications have been extended to the realms of CTO intervention, aneurysmal coronary disease, and iatrogenic/spontaneous coronary artery dissection. IVUS is also a proven cost-effective strategy. Nevertheless, despite these benefits, the global uptake of IVUS-guided PCI remains low.

Summary

IVUS plays a pivotal role during PCI, particularly complex calcific and long lesions. IVUS-guided PCI is safe, cost-effective, and associates with substantial reductions in MACE. However, the worldwide uptake of IVUS-guided PCI remains considerably low. Further efforts are required to promote this evidence-based PCI strategy among the global interventional cardiology community to further improve the outcomes of our PCI candidates.
Literatur
1.
• Gao XF, Wang ZM, Wang F, et al. Intravascular ultrasound guidance reduces cardiac death and coronary revascularization in patients undergoing drug-eluting stent implantation: results from a meta-analysis of 9 randomized trials and 4724 patients. Int J Cardiovasc Imaging. 2019;35(2):239–47 Gao et al 2019. Meta-analysis of 9 randomized trials and 4724 patients undergoing PCI with drug eluting stents. IVUS guided PCI demonstrated significant reduction in cardiac death, coronary revascularization and stent thrombosis when compared to conventional angiography.PubMedCrossRef
2.
• Ye Y, Yang M, Zhang S, Zeng Y. Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound: a meta-analysis. PLoS One. 2017;12(6):e0179756 Ye et al 2017. Meta-analysis of 6,480 patients undergoing LMCA PCI. IVUS guided PCI showed substantial reduction in all-cause death, cardiac death, target lesion revascularization and stent thrombosis when compared to conventional angiography.PubMedPubMedCentralCrossRef
3.
Elgendy IY, Mahmoud AN, Elgendy AY, Bavry AA. Outcomes with intravascular ultrasound-guided stent implantation: a meta-analysis of randomized trials in the era of drug-eluting stents. Circ Cardiovasc interven. 2016;9(4):e003700.CrossRef
4.
Jakabcin J, Spacek R, Bystron M, Kvasnák M, Jager J, Veselka J, et al. Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS. Catheter Cardiovasc Interv. 2010;75(4):578–83.PubMedCrossRef
5.
Chieffo A, Latib A, Caussin C, Presbitero P, Galli S, Menozzi A, et al. A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial. Am Heart J. 2013;165(1):65–72.PubMedCrossRef
6.
Yoon YW, Shin S, Kim BK, Kim JS, Shin DH, Ko YG, et al. Usefulness of intravascular ultrasound to predict outcomes in short-length lesions treated with drug-eluting stents. Am J Cardiol. 2013;112(5):642–6.PubMedCrossRef
7.
• Hong S-J, Mintz GS, Ahn C-M, et al. Effect of intravascular ultrasound-guided drug-eluting stent implantation: five-year follow-up of the IVUS-XPL randomized trial. JACC: Cardiovasc Intervent. 2019:4705. Hong 2019. Randomized trial of 1,400 patients with long coronary lesions (≥28mm length) comparing IVUS guided PCI to conventional angiography. IVUS guided PCI was associated with significant reduction in rates of major adverse cardiac events at 5 years.
8.
Tian NL, Gami SK, Ye F, et al. Angiographic and clinical comparisons of intravascular ultrasound- versus angiography-guided drug-eluting stent implantation for patients with chronic total occlusion lesions: two-year results from a randomised AIR-CTO study. EuroIntervention. 2015;10(12):1409–17.PubMedCrossRef
9.
Kim BK, Shin DH, Hong MK, et al. Clinical impact of intravascular ultrasound-guided chronic total occlusion intervention with zotarolimus-eluting versus biolimus-eluting stent implantation: randomized study. Circ Cardiovasc interven. 2015;8(7):002592.CrossRef
10.
Tan Q, Wang Q, Liu D, Zhang S, Zhang Y, Li Y. Intravascular ultrasound-guided unprotected left main coronary artery stenting in the elderly. Saudi Med J. 2015;36(5):549–53.PubMedPubMedCentralCrossRef
11.
Ali ZA, Maehara A, Généreux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet. 2016;388(10060):2618–28.PubMedCrossRef
12.
Zhang J, Gao X, Kan J, et al. Intravascular ultrasound versus angiography-guided drug-eluting stent implantation. J Am Coll Cardiol. 2018;72(24):3126.PubMedCrossRef
13.
Neumann F-J, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018;40(2):87–165.CrossRef
14.
Johnson TW, Raber L, di Mario C, et al. Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2019;40(31):2566–84.PubMedCrossRef
15.
de la Torre Hernandez JM, Hernandez Hernandez F, Alfonso F, et al. Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study. J Am Coll Cardiol. 2011;58(4):351–8.PubMedCrossRef
16.
Jasti V, Ivan E, Yalamanchili V, Wongpraparut N, Leesar MA. Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis. Circulation. 2004;110(18):2831–6.PubMedCrossRef
17.
Rusinova RP, Mintz GS, Choi SY, Araki H, Hakim D, Sanidas E, et al. Intravascular ultrasound comparison of left main coronary artery disease between white and Asian patients. Am J Cardiol. 2013;111(7):979–84.PubMedCrossRef
18.
Oviedo C, Maehara A, Mintz GS, et al. Intravascular ultrasound classification of plaque distribution in left main coronary artery bifurcations: where is the plaque really located? Circ Cardiovasc interven. 2010;3(2):105–12.CrossRef
19.
Sato K, Naganuma T, Costopoulos C, Takebayashi H, Goto K, Miyazaki T, et al. Calcification analysis by intravascular ultrasound to define a predictor of left circumflex narrowing after cross-over stenting for unprotected left main bifurcation lesions. Cardiovasc Revasculariz Med. 2014;15(2):80–5.CrossRef
20.
Medina A, Martin P, Suarez de Lezo J, et al. Vulnerable carina anatomy and ostial lesions in the left anterior descending coronary artery after floating-stent treatment. Rev Esp Cardiol. 2009;62(11):1240–9.PubMedCrossRef
21.
Wang Y, Mintz GS, Gu Z, Qi Y, Liu M, Wu X. Meta-analysis and systematic review of intravascular ultrasound versus angiography-guided drug eluting stent implantation in left main coronary disease in 4592 patients. BMC Cardiovasc Disord. 2018;18(1):018–0843.CrossRef
22.
Liu XM, Yang ZM, Liu XK, et al. Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions: a single-center randomized trial. Anatol J Cardiol. 2019;21(2):83–90.PubMed
23.
Agostoni P, Valgimigli M, Van Mieghem CA, et al. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. Am J Cardiol. 2005;95(5):644–7.PubMedCrossRef
24.
Park SJ, Kim YH, Park DW, Lee SW, Kim WJ, Suh J, et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Intervent. 2009;2(3):167–77.CrossRef
25.
de la Torre Hernandez JM, Baz Alonso JA, Gomez Hospital JA, et al. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries. JACC Cardiovasc Interv. 2014;7(3):244–54.PubMedCrossRef
26.
Gao XF, Kan J, Zhang YJ, Zhang JJ, Tian NL, Ye F, et al. Comparison of one-year clinical outcomes between intravascular ultrasound-guided versus angiography-guided implantation of drug-eluting stents for left main lesions: a single-center analysis of a 1,016-patient cohort. Patient Prefer Adher. 2014;8:1299–309.CrossRef
27.
Kim YH, Her AY, Rha SW, et al. Three-year major clinical outcomes of angiography-guided single stenting technique in non-complex left main coronary artery diseases. Int Heart J. 2017;58(5):704–13.PubMedCrossRef
28.
Tian J, Guan C, Wang W, et al. Intravascular ultrasound guidance improves the long-term prognosis in patients with unprotected left main coronary artery disease undergoing percutaneous coronary intervention. Sci Rep. 2017;7(1):2377.PubMedPubMedCentralCrossRef
29.
Andell P, Karlsson S, Mohammad MA, et al. Intravascular ultrasound guidance is associated with better outcome in patients undergoing unprotected left main coronary artery stenting compared with angiography guidance alone. Circ Cardiovasc Interv. 2017;10(5):004813.CrossRef
30.
Mintz GS. Intravascular imaging of coronary calcification and its clinical implications. J Am Coll Cardiol Img. 2015;8(4):461–71.CrossRef
31.
de Ribamar Costa J Jr, Mintz GS, Carlier SG, et al. Intravascular ultrasound assessment of drug-eluting stent expansion. Am Heart J. 2007;153(2):297–303.PubMedCrossRef
32.
Mintz GS. Intravascular ultrasound and outcomes after drug-eluting stent implantation. Coron Artery Dis. 2017;28(4):346–52.PubMedCrossRef
33.
Morino Y, Tamiya S, Masuda N, et al. Intravascular ultrasound criteria for determination of optimal longitudinal positioning of sirolimus-eluting stents. Circ J. 2010;74(8):1609–16.PubMedCrossRef
34.
Pu J, Mintz GS, Biro S, Lee JB, Sum ST, Madden SP, et al. Insights into echo-attenuated plaques, echolucent plaques, and plaques with spotty calcification: novel findings from comparisons among intravascular ultrasound, near-infrared spectroscopy, and pathological histology in 2,294 human coronary artery segments. J Am Coll Cardiol. 2014;63(21):2220–33.PubMedCrossRef
35.
Patel VG, Brayton KM, Mintz GS, Maehara A, Banerjee S, Brilakis ES. Intracoronary and noninvasive imaging for prediction of distal embolization and periprocedural myocardial infarction during native coronary artery percutaneous intervention. Circ Cardiovasc Imaging. 2013;6(6):1102–14.PubMedCrossRef
36.
Endo M, Hibi K, Shimizu T, Komura N, Kusama I, Otsuka F, et al. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2010;3(5):540–9.PubMedCrossRef
37.
Stone GW, Maehara A, Muller JE, Rizik DG, Shunk KA, Ben-Yehuda O, et al. Plaque characterization to inform the prediction and prevention of periprocedural myocardial infarction during percutaneous coronary intervention: the CANARY trial (coronary assessment by near-infrared of atherosclerotic rupture-prone yellow). JACC Cardiovasc Interv. 2015;8(7):927–36.PubMedCrossRef
38.
Hibi K, Kozuma K, Sonoda S, et al. A randomized study of distal filter protection versus conventional treatment during percutaneous coronary intervention in patients with attenuated plaque identified by intravascular ultrasound. JACC Cardiovasc Interven. 2018;11(16):1545–55.CrossRef
39.
Mangiacapra F, Peace AJ, Di Serafino L, et al. Intracoronary EnalaPrilat to reduce MICROvascular damage during percutaneous coronary intervention (ProMicro) study. J Am Coll Cardiol. 2013;61(6):615–21.PubMedCrossRef
40.
Kostamaa H, Donovan J, Kasaoka S, Tobis J, Fitzpatrick L. Calcified plaque cross-sectional area in human arteries: correlation between intravascular ultrasound and undecalcified histology. Am Heart J. 1999;137(3):482–8.PubMedCrossRef
41.
Hoffmann R, Mintz GS, Popma JJ, Satler LF, Kent KM, Pichard AD, et al. Treatment of calcified coronary lesions with Palmaz-Schatz stents. An intravascular ultrasound study. Eur Heart J. 1998;19(8):1224–31.PubMedCrossRef
42.
Sakakura K, Yamamoto K, Taniguchi Y, Tsurumaki Y, Momomura S-I, Fujita H. Intravascular ultrasound enhances the safety of rotational atherectomy. Cardiovasc Revasculariz Med. 2018;19(3, Part A):286–91.CrossRef
43.
Mintz GS, Weissman NJ, Fitzgerald PJ. Intravascular ultrasound assessment of the mechanisms and results of brachytherapy. Circulation. 2001;104(11):1320–5.PubMedCrossRef
44.
Mintz GS, Kovach JA, Javier SP, et al. Mechanisms of lumen enlargement after excimer laser coronary angioplasty. An intravascular ultrasound study. Circulation. 1995;92(12):3408–14.PubMedCrossRef
45.
Rossi J, Hill T, Khatri J. Treatment of diffuse right coronary aneurysmal disease with standard drug-eluting stent scaffolding of polytetrafluoroethylene-covered stents. J Invasive Cardiol. 2018;30(5):E42–e43.PubMed
46.
Dutary J, Zakhem B, DE Lucas CB, Paulo M, Gonzalo N, Alfonso F. Treatment of a giant coronary artery aneurysm: intravascular ultrasound and optical coherence tomography findings. J Interv Cardiol. 2012;25(1):82–5.PubMedCrossRef
47.
de Jaegere P, Mudra H, Figulla H, et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the multicenter ultrasound stenting in coronaries study (MUSIC study). Eur Heart J. 1998;19(8):1214–23.PubMedCrossRef
48.
Oemrawsingh PV, Mintz GS, Schalij MJ, Zwinderman AH, Jukema JW, van der Wall EE. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP study). Circulation. 2003;107(1):62–7.PubMedCrossRef
49.
Schiele F, Meneveau N, Vuillemenot A, et al. Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate: a multicenter, randomized study comparing two strategies--with and without intravascular ultrasound guidance. RESIST study group. REStenosis after Ivus guided STenting. J Am Coll Cardiol. 1998;32(2):320–8.PubMedCrossRef
50.
Russo RJ, Silva PD, Teirstein PS, et al. A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID trial). Circ Cardiovasc Interv. 2009;2(2):113–23.PubMedCrossRef
51.
Schiele F, Meneveau N, Gilard M, Boschat J, Commeau P, Ming LP, et al. Intravascular ultrasound-guided balloon angioplasty compared with stent: immediate and 6-month results of the multicenter, randomized balloon equivalent to stent study (BEST). Circulation. 2003;107(4):545–51.PubMedCrossRef
52.
Frey AW, Hodgson JM, Muller C, Bestehorn HP, Roskamm H. Ultrasound-guided strategy for provisional stenting with focal balloon combination catheter: results from the randomized strategy for intracoronary ultrasound-guided PTCA and stenting (SIPS) trial. Circulation. 2000;102(20):2497–502.PubMedCrossRef
53.
Kang SJ, Ahn JM, Song H, Kim WJ, Lee JY, Park DW, et al. Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease. Circ Cardiovasc Interv. 2011;4(6):562–9.PubMedCrossRef
54.
Maluenda G, Ben-Dor I, Gaglia MA Jr, et al. Clinical outcomes and treatment after drug-eluting stent failure: the absence of traditional risk factors for in-stent restenosis. Circ Cardiovasc Intervent. 2012;5(1):12–9.CrossRef
55.
Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005;45(7):995–8.PubMedCrossRef
56.
Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, et al. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent trials. JACC Cardiovasc Interven. 2009;2(12):1269–75.CrossRef
57.
Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol. 2004;43(11):1959–63.PubMedCrossRef
58.
Cheneau E, Leborgne L, Mintz GS, et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation. 2003;108(1):43–7.PubMedCrossRef
59.
Choi SY, Witzenbichler B, Maehara A, Lansky AJ, Guagliumi G, Brodie B, et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) substudy. Circ Cardiovasc Interv. 2011;4(3):239–47.PubMedCrossRef
60.
Qiu F, Mintz GS, Witzenbichler B, Metzger DC, Rinaldi MJ, Duffy PL, et al. Prevalence and clinical impact of tissue protrusion after stent implantation: an ADAPT-DES intravascular ultrasound substudy. JACC Cardiovasc Interven. 2016;9(14):1499–507.CrossRef
61.
Ryan N, Gonzalo N, Dingli P, Cruz OV, Jiménez-Quevedo P, Nombela-Franco L, et al. Intravascular ultrasound guidance of percutaneous coronary intervention in ostial chronic total occlusions: a description of the technique and procedural results. Int J Cardiovasc Imaging. 2017;33(6):807–13.PubMedCrossRef
62.
Dai J, Katoh O, Kyo E, Tsuji T, Watanabe S, Ohya H. Approach for chronic total occlusion with intravascular ultrasound-guided reverse controlled antegrade and retrograde tracking technique: single center experience. J Interv Cardiol. 2013;26(5):434–43.PubMedCrossRef
63.
Hong SJ, Kim BK, Shin DH, et al. Usefulness of intravascular ultrasound guidance in percutaneous coronary intervention with second-generation drug-eluting stents for chronic total occlusions (from the Multicenter Korean-Chronic Total Occlusion Registry). Am J Cardiol. 2014;114(4):534–40.PubMedCrossRef
64.
Hayes Sharonne N, Kim Esther SH, Saw J, et al. Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association. Circulation. 2018;137(19):e523–57.PubMedPubMedCentral
65.
Maehara A, Mintz GS, Castagna MT, Pichard AD, Satler LF, Waksman R, et al. Intravascular ultrasound assessment of spontaneous coronary artery dissection. Am J Cardiol. 2002;89(4):466–8.PubMedCrossRef
66.
Ahmed MA, Hamra M, Ali M, Abdullah AS, Arnous S, Kiernan TJ. Spontaneous coronary artery dissection, challenges of diagnosis and management. Futur Cardiol. 2017;13(6):539–49.CrossRef
67.
Hiraide T, Sawano M, Shiraishi Y, Ueda I, Numasawa Y, Noma S, et al. Impact of catheter-induced iatrogenic coronary artery dissection with or without postprocedural flow impairment: a report from a Japanese multicenter percutaneous coronary intervention registry. PLoS One. 2018;13(9):e0204333.PubMedPubMedCentralCrossRef
68.
Cheng C-I, Wu C-J, Hsieh Y-K, Chen YH, Chen CJ, Chen SM, et al. Percutaneous coronary intervention for iatrogenic left main coronary artery dissection. Int J Cardiol. 2008;126(2):177–82.PubMedCrossRef
69.
Eshtehardi P, Adorjan P, Togni M, Tevaearai H, Vogel R, Seiler C, et al. Iatrogenic left main coronary artery dissection: incidence, classification, management, and long-term follow-up. Am Heart J. 2010;159(6):1147–53.PubMedCrossRef
70.
71.
Wichmann Julian L, Katzberg Richard W, Litwin Sheldon E, et al. Contrast-induced nephropathy. Circulation. 2015;132(20):1931–6.PubMedCrossRef
72.
Sakai K, Ikari Y, Nanasato M, Umetsu H, Okutsu M, Takikawa T, et al. Impact of intravascular ultrasound-guided minimum-contrast coronary intervention on 1-year clinical outcomes in patients with stage 4 or 5 advanced chronic kidney disease. Cardiovasc Interv Ther. 2019;34(3):234–41.PubMedCrossRef
73.
Mariani J Jr, Guedes C, Soares P, et al. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (minimizing contrast utiliZation with IVUS guidance in coronary angioplasty) randomized controlled trial. JACC Cardiovasc Interv. 2014;7(11):1287–93.PubMedPubMedCentralCrossRef
74.
Nayak KR, Mehta HS, Price MJ, Russo RJ, Stinis CT, Moses JW, et al. A novel technique for ultra-low contrast administration during angiography or intervention. Catheter Cardiovasc Interv. 2010;75(7):1076–83.PubMed
75.
Ali ZA, Karimi Galougahi K, Nazif T, Maehara A, Hardy MA, Cohen DJ, et al. Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. Eur Heart J. 2016;37(40):3090–5.PubMedPubMedCentralCrossRef
76.
Sacha J, Gierlotka M, Feusette P, Dudek D. Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review. Postepy Kardiol Interwencyjnej. 2019;15(2):127–36.PubMedPubMedCentral
77.
Nagaoka M, Tsumuraya N, Nie M, Ikari Y. Zero contrast coronary intervention using intravascular ultrasound guidance in a patient with allergy to contrast medium. Tokai J Exp Clin Med. 2016;41(3):152–5.PubMed
78.
van der Wal WM, Noordzij M, Dekker FW, et al. Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant. 2011;26(9):2978–83.PubMedCrossRef
79.
Karimi Galougahi K, Mintz GS, Karmpaliotis D, Ali ZA. Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy. Catheter Cardiovasc Interv. 2017;90(4):E85–e89.PubMedCrossRef
80.
Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation. 2001;103(4):604–16.PubMedCrossRef
81.
Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226–35.PubMedCrossRef
82.
Kawasaki D, Fujii K, Fukunaga M, et al. Safety and efficacy of carbon dioxide and intravascular ultrasound-guided stenting for renal artery stenosis in patients with chronic renal insufficiency. Angiology. 2015;66(3):231–6.PubMedCrossRef
83.
van der Sijde JN, Karanasos A, van Ditzhuijzen NS, et al. Safety of optical coherence tomography in daily practice: a comparison with intravascular ultrasound. Eur Heart J Cardiovasc Imaging. 2017;18(4):467–74.PubMed
84.
Ahn JM, Kang SJ, Yoon SH, et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol. 2014;113(8):1338–47.PubMedCrossRef
85.
Alberti A, Giudice P, Gelera A, Stefanini L, Priest V, Simmonds M, et al. Understanding the economic impact of intravascular ultrasound (IVUS). Eur J Health Econ. 2016;17(2):185–93.PubMedCrossRef
86.
Maehara A, Weisz G, Neumann F-J, et al. TCT-68 Does IVUS Reduce Stent Thrombosis with DES? Two-year results from the prospective, multicenter ADAPT-DES study. J Am Coll Cardiol. 2013;62(18 Supplement 1):B21.CrossRef
87.
Witzenbichler B, Maehara A, Weisz G, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study. Circulation. 2014;129(4):463–70.PubMedCrossRef
88.
von Birgelen C, Zocca P, Buiten RA, et al. Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial. Lancet. 2018;392(10154):1235–45.CrossRef
89.
Pilgrim T, Heg D, Roffi M, et al. Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial. Lancet. 2014;384(9960):2111–22.PubMedCrossRef
90.
von Birgelen C, Kok MM, van der Heijden LC, et al. Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial. Lancet. 2016;388(10060):2607–17.CrossRef
91.
Buccheri S, James S, Lindholm D, Fröbert O, Olivecrona GK, Persson J, et al. Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden: a report from the Swedish coronary and angioplasty registry (SCAAR). Eur Heart J. 2019;40(31):2607–15.PubMedCrossRef
92.
Waltenberger J, Brachmann J, van der Heyden J, et al. (2019) Five-year results of the BIOFLOW-III registry: real-world experience with a biodegradable polymer sirolimus-eluting stent. Cardiovasc Revasc Med
93.
Trabattoni D, Fabbiocchi F, Montorsi P, Galli S, Ravagnani P, Calligaris G, et al. A long-term single-center registry of 6893 patients undergoing elective percutaneous coronary intervention with the Xience everolimus-eluting stent. J Invasive Cardiol. 2019;31(5):146–51.PubMed
94.
von Birgelen C, van der Heijden LC, Basalus MWZ, et al. Five-year outcome after implantation of zotarolimus- and everolimus-eluting stents in randomized trial participants and nonenrolled eligible patients: a secondary analysis of a randomized clinical trial. JAMA Cardiol. 2017;2(3):268–76.CrossRef
95.
Ormiston J, Motreff P, Darremont O, Webber B, Guerin P, Webster M. Bioresorbable scaffolds on the bench. EuroIntervention. 2015;11 Suppl V:V166–9.PubMedCrossRef
96.
Valle JA, Tamez H, Abbott JD, Moussa ID, Messenger JC, Waldo SW, et al. Contemporary use and trends in unprotected leftm coronary artery percutaneous coronary intervention in the United States: an analysis of the National Cardiovascular Data Registry Research to practice initiative. JAMA Cardiol. 2019;4(2):100–9.PubMedPubMedCentralCrossRef
Metadaten
Titel
Improving Outcomes With IVUS Guidance During Percutaneous Coronary Interventions
verfasst von
Vinayak Nagaraja
Ankur Kalra
Rishi Puri
Publikationsdatum
01.05.2020
Verlag
Springer US
Erschienen in
Current Treatment Options in Cardiovascular Medicine / Ausgabe 5/2020
Print ISSN: 1092-8464
Elektronische ISSN: 1534-3189
DOI
https://doi.org/10.1007/s11936-020-00810-4

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise